XML 35 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
SEGMENTED INFORMATION
12 Months Ended
Sep. 30, 2022
SEGMENTED INFORMATION  
SEGMENTED INFORMATION

13.    SEGMENTED INFORMATION

The Company works in one industry being the development of small molecule drugs for prostate cancer. The Company’s right of use asset is located in the USA.